Revenue | ₹344.68Cr |
Net Profits | ₹41.27Cr |
Net Profit Margins | 11.97% |
Corona Remedies Ltd’s revenue jumped 15.42% since last year same period to ₹344.68Cr in the Q3 2025-2026. On a quarterly growth basis, Corona Remedies Ltd has generated -5.2% fall in its revenue since last 3-months.
Corona Remedies Ltd’s net profit fell -8.19% since last year same period to ₹41.27Cr in the Q3 2025-2026. On a quarterly growth basis, Corona Remedies Ltd has generated -21.12% fall in its net profits since last 3-months.
Corona Remedies Ltd’s net profit margin fell -20.45% since last year same period to 11.97% in the Q3 2025-2026. On a quarterly growth basis, Corona Remedies Ltd has generated -16.8% fall in its net profit margins since last 3-months.
The revenue for Corona Remedies Ltd in the Q3 results 2025 was ₹344.68Cr.
The net profit for Corona Remedies Ltd in the Q3 results 2025 was ₹41.27Cr.
The net profit margin for Corona Remedies Ltd in the Q3 results 2025 was 11.97%.
The revenue for Corona Remedies Ltd in the Q3 results 2024 was ₹298.63Cr.
The net profit for Corona Remedies Ltd in the Q3 results 2024 was ₹44.95Cr.
The net profit margin for Corona Remedies Ltd in the Q3 results 2024 was 15.05%.